chronic wounds epidemiology forecast
DelveInsight’s ‘Chronic Wounds- Epidemiology Forecast–2034’ report delivers an in-depth understanding of the Chronic Wounds, historical and forecasted epidemiology as well as the Chronic Wounds trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2021-2034
Chronic Wounds Disease Understanding
Chronic wounds, are defined as the wounds with an inability to heal within an anticipated time frame. They are widespread and frequently mistreated. A wound is considered chronic or non-healing when it has not fully healed even after four to six weeks of screening. Venous ulcer (VU [Vein ulcers, arterial ulcers]), diabetic foot ulcers (DFU), and pressure ulcers (PU) are examples of common chronic wound types.
While different etiologies of chronic wounds are associated with slightly different symptoms, the most common way to recognize a chronic wound is by its elevated, hyper proliferative, yet immobile wound edge. There will be inflammation in the vicinity of the wound, which could harm the healing process. Other common sign and symptom checklist include: Bleeding, swelling, pain or blistering, darkened skin around the wound, difficulty moving the injured area, enlarged or deepened injury, fever, itching, milky pus, and warmth or heat when touched.
Chronic Wounds Diagnosis
The first step in the clinical evaluation of a wound is to decide if it is an acute or chronic wound. Wound assessment starts with a careful physical examination. Location, size and depth of wound; presence of drainage; and tissue type are documented. Based on location and appearance, most chronic wounds can be classified by etiology, allowing for appropriate assessment and treatment recommendations.
Continued in the report…..
Chronic Wounds Epidemiology Perspective by DelveInsight
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Prevalent Cases of Chronic Wounds, and Type-specific Diagnosed Prevalent Cases of Chronic Wounds, in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan, from 2021 to 2034.
Chronic Wounds Detailed Epidemiology Segmentation
- In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of Chronic Wounds in the 7MM were 7,037,816 in 2021.
- The highest total diagnosed prevalent cases of Chronic Wounds were accounted by the US in 2021 (4,140,580 cases), which are expected to show a rise in the future.
- Among the European countries, Germany had the highest diagnosed prevalent cases of Chronic Wounds with 602,682 cases, followed by France, which had 486,121 cases in 2021. On the other hand, in the same year Spain had the lowest diagnosed prevalent population (336,316 cases).
- Japan had 553,799 total diagnosed prevalent cases of Chronic Wounds in 2021, accounting for approximately 8% in the 7MM.
- During the peak year of COVID-19 pandemic, a steep decline in the cases of Chronic Wounds was recorded throughout the 7MM.
Scope of the Report
- The report covers the descriptive overview of Chronic Wounds, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
- The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The report assesses the disease risk and burden of Chronic Wounds.
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
Report Highlights
- 10-year forecast of Chronic Wounds
- 7MM Coverage
- Total Diagnosed Prevalent Cases of Chronic Wounds
Key Questions Answered
- What are the disease risk and burden of Chronic Wounds?
- What is the historical Chronic Wounds patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
- What would be the forecasted patient pool of Chronic Wounds at the 7MM level?
- What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Chronic Wounds?
- Out of the above-mentioned countries, which country would have the highest prevalent population of Chronic Wounds during the forecast period (2025-2034)?
- At what CAGR the population is expected to grow across the 7MM during the forecast period (2025-2034)?
Reasons to buy
The Chronic Wounds report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the 7MM+ Chronic Wounds epidemiology forecast.
- The Chronic Wounds epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
- The Chronic Wounds epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of Disease by segmentation
- Factors driving growth in a specific patient population
1. Key Insights
2. Report Introduction
3. Chronic Wounds Epidemiology Overview at a Glance
3.1. Patient Share (%) Distribution of Chronic Wounds in 2021
3.2. Patient Share (%) Distribution of Chronic Wounds in 2034
4. Executive Summary of Chronic Wounds
5. Disease Background and Overview: Chronic Wounds
5.1. Introduction
5.2. Types of Chronic Wounds
5.3. Risk Factors of Chronic Wounds
5.4. Causes of Chronic Wounds According to Types
5.5. Signs and Symptoms of Chronic Wounds
5.6. Pathophysiology of Chronic Wounds
5.6.1. The role of inflammation in the pathophysiology of common chronic wounds
5.7. Diagnosis
5.7.1. Diagnostic Algorithm
5.7.2. Diagnostic Guidelines
6. Epidemiology and Patient Population
6.1. Key Findings
6.2. Methodology of Epidemiology
6.3. Assumptions and Rationale: 7MM
6.4. Total Diagnosed Prevalent Cases of Chronic Wounds in the 7MM
6.5. The United States
6.5.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.5.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
6.6. Major Five European Countries
6.6.1. Germany
6.6.1.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.6.1.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
6.6.2. France
6.6.2.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.6.2.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
6.6.3. Italy
6.6.3.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.6.3.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
6.6.4. Spain
6.6.4.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.6.4.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
6.6.5. The United Kingdom
6.6.5.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.6.5.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
6.7. Japan Epidemiology
6.7.1. Total Diagnosed Prevalent Cases of Chronic Wounds
6.7.2. Type-specific Diagnosed Prevalent Cases of Chronic Wounds
7. Patient Journey
8. Key Opinion Leaders’ Views
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
List of Tables:
List of Tables
Table 1: Summary of Chronic Wound Epidemiology (2021-2034)
Table 2: Systemic and Local Factors Contributing to Chronic Wounds
Table 3: PUs Grading System, NPUAP, EPUAP, and PPPIA
Table 4: Types of Chronic Wounds and Their Pathology
Table 5: Extended Differential Diagnosis for Chronic Wounds
Table 6: Clinical Practice Guideline for the Diagnosis of DFIs
Table 7: Guidelines on the diagnosis of foot infections in persons with diabetes
Table 8: Guidelines for the Diagnosis for Pus: JDA
Table 9: TIME Principles of Wound Bed Preparation
Table 10: Total Diagnosed Prevalent Cases of Chronic Wounds in the 7MM (2021-2034)
Table 11: Total Diagnosed Prevalent Cases of Chronic Wounds in the US (2021-2034)
Table 12: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in the US (2021-2034)
Table 13: Total Diagnosed Prevalent Cases of Chronic Wounds in the EU-5 (2021-2034)
Table 14: Total Diagnosed Prevalent Cases of Chronic Wounds in Germany (2021-2034)
Table 15: Total Diagnosed Prevalent Cases of Chronic Wounds in France (2021-2034)
Table 16: Total Diagnosed Prevalent Cases of Chronic Wounds in Italy (2021-2034)
Table 17: Total Diagnosed Prevalent Cases of Chronic Wounds in Spain (2021-2034)
Table 18: Total Diagnosed Prevalent Cases of Chronic Wounds in the UK (2021-2034)
Table 19: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in the EU-5 (2021-2034)
Table 20: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Germany (2021-2034)
Table 21: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in France (2021-2034)
Table 22: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Italy (2021-2034)
Table 23: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Spain (2021-2034)
Table 24: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in the UK (2021-2034)
Table 25: Total Diagnosed Prevalent Cases of Chronic Wounds in Japan (2021-2034)
Table 26: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Japan (2021-2034)
List of Figures:
List of Figures
Figure 1: Chronic Non-healing wounds
Figure 2: Flow Diagram of Chronic Wound Management
Figure 3: Types of Chronic Wounds
Figure 4: Arterial Insufficiency Ulcer Located at Weight Bearing Surface.
Figure 5: Diabetic Foot Ulcer (DFU) at First Metatarsal Head of the Foot
Figure 6: Stages of PUs
Figure 7: Molecular and Cellular Deficiencies in Chronic Wounds (red circles) and Factors Required to Overcome Them (green rectangles)
Figure 8: Pathophysiology of Chronic Wounds
Figure 9: The Role of Inflammation in the Pathophysiology of Common Chronic Wounds
Figure 10: Diagnosing Chronic Wounds: The ABCDE Rule
Figure 11: Diagnostic Algorithm to Determine Chronic Wound
Figure 12: Total Diagnosed Prevalent Cases of Chronic Wounds in the 7MM (2021-2034)
Figure 13: Total Diagnosed Prevalent Cases of Chronic Wounds in the US (2021-2034)
Figure 14: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in the US (2021-2034)
Figure 15: Total Diagnosed Prevalent Cases of Chronic Wounds in the EU-5 (2021-2034)
Figure 16: Total Diagnosed Prevalent Cases of Chronic Wounds in Germany (2021-2034)
Figure 17: Total Diagnosed Prevalent Cases of Chronic Wounds in France (2021-2034)
Figure 18: Total Diagnosed Prevalent Cases of Chronic Wounds in Italy (2021-2034)
Figure 19: Total Diagnosed Prevalent Cases of Chronic Wounds in Spain (2021-2034)
Figure 20: Total Diagnosed Prevalent Cases of Chronic Wounds in the UK (2021-2034)
Figure 21: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in the EU-5 (2021-2034)
Figure 22: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Germany (2021-2034)
Figure 23: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in France (2021-2034)
Figure 24: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Italy (2021-2034)
Figure 25: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Spain (2021-2034)
Figure 26: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in the UK (2021-2034)
Figure 27: Total Diagnosed Prevalent Cases of Chronic Wounds in Japan (2021-2034)
Figure 28: Type-specific Diagnosed Prevalent Cases of Chronic Wounds in Japan (2021-2034)
Figure 29: Patient Journey of Chronic Wounds